| Term 
 
        | What is the MOA of adrenergic neurotransmission? |  | Definition 
 
        | Tyrosine enters and is reduced by Tyrosine hydroxylase to Dopa; Dopa is converted to Dopamine which is then converted to NE and stored in vessicles until released into the synapse. |  | 
        |  | 
        
        | Term 
 
        | What is the MOA for terminating the effect of NE? |  | Definition 
 
        | Combination of reuptake and enyzmatic degredation. *NET (NE transporter) reuptake
 *MAO (monoamine oxyidase) degredation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. catechol 2. phenylethylamine
 3. norepinephrine
 4. epinephrine
 5. isoproterenol
 6. dopamine
 |  | 
        |  | 
        
        | Term 
 
        | A cocaine of a tricyclic antidepressant would be classified as an ___. Why? |  | Definition 
 
        | *indirect working agonist *because it will bind to the NE reuptake transporter thus increase the amount of NE remaining available in the synapse
 |  | 
        |  | 
        
        | Term 
 
        | Epinephrine is a hormone from the ___. |  | Definition 
 
        | Adrenal medula. It lacks a methyl group that NE has.
 |  | 
        |  | 
        
        | Term 
 
        | Alpha and Beta receptors are all ___ receptors. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the typical location of the Alpha 1 receptor? What are the subtypes? |  | Definition 
 
        | *post-synaptic effector cells of most vascular smooth muscle; puliary dilator muscle; protate * 1A, 1B, 1D
 |  | 
        |  | 
        
        | Term 
 
        | What is the result of ligand binding/action of the Alpha 1 receptor? |  | Definition 
 
        | *increase in intracellular Ca2+, vasoconstriction; contraction |  | 
        |  | 
        
        | Term 
 
        | What is the typical location of the Alpha 2 receptor? What are the subtypes? |  | Definition 
 
        | *post-synaptic receptors in CNS, adrenergic nerve terminals * 2A, 2B, 2C
 |  | 
        |  | 
        
        | Term 
 
        | What is the result of ligand binding/action of the Alpha 2 receptor? |  | Definition 
 
        | *inhibition of adenylate cyclase; *decrease in cAMP/opens K+ channel/inhibition of neurotransmitter release *stimulation produces autoregulatory effect in terms of regulating the activity of simpathetic outflow
 *inhibits stimulation of simpathetic outflow
 *inhibit by hyperpolarizing
 |  | 
        |  | 
        
        | Term 
 
        | What is the typical location of the Beta 1 receptor? |  | Definition 
 
        | *heart, juxtablomerular cells, lipocytes, CNS, ciliary body |  | 
        |  | 
        
        | Term 
 
        | What is the result of ligand binding/action of the Beta 1 receptor? |  | Definition 
 
        | *stimulation of the adenylate cyclase; increase in cAMP/Positive chronotropy and inotropy; renin release *increase heart rate and force of contraction thus combined leads to increaesed cardiac output.
 |  | 
        |  | 
        
        | Term 
 
        | What does cardiac output depend on? |  | Definition 
 
        | stroke volume and heart rate |  | 
        |  | 
        
        | Term 
 
        | What is the typical location of Beta 2 receptors? |  | Definition 
 
        | *respiratory uterine and vascular smooth muscle *mainly present in areteries going to skeletal muscle as opposed to vascular smooth muscle in the Alpha 1
 |  | 
        |  | 
        
        | Term 
 
        | What is the result of ligand binding/action of the Beta 2 receptor? |  | Definition 
 
        | *vaso dilation of the arteries going to  skeletal muscle *stimulation of adenylate cyclase; increase in cAMP/smooth muscle relaxation
 |  | 
        |  | 
        
        | Term 
 
        | What is the typical location of the D1(dopamine 1) receptor? |  | Definition 
 
        | *renal, mesenteric, coronary and cerebral blood vessels |  | 
        |  | 
        
        | Term 
 
        | What is the result of ligand binding/action of the D1 receptor? |  | Definition 
 
        | *vasodilation of renal arteries with increase in blood flow and filtration rate (promotes excretion of fluids) *inhibition of NA/H pump
 |  | 
        |  | 
        
        | Term 
 
        | What is the typical location of D2 (dopamine 2) receptor? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the result of ligand binding/action of the D2 receptor? |  | Definition 
 
        | *inhibition of adenylate cyclase; decreasein cAMP; modulates neurotransmitter release |  | 
        |  | 
        
        | Term 
 
        | How do A2 and B signaling oppose each other? |  | Definition 
 
        | *A2 inhibits adenylate cyclase and B1 stimulates it |  | 
        |  | 
        
        | Term 
 
        | What are the classes of adrenergic agaonists? |  | Definition 
 
        | 1. direct acting 2. mixed acting
 3. indirect-acting
 |  | 
        |  | 
        
        | Term 
 
        | What are the classes of indirect-acting Adrenergic Agonists? |  | Definition 
 
        | 1. releaseing agents 2. utake inhibitor
 3. MAO/COMT inhibitors
 |  | 
        |  | 
        
        | Term 
 
        | What are the classes of Direct Acting Adrenergic Agonists? |  | Definition 
 
        | 1. Secective 2. Non-selective
 |  | 
        |  |